(Q50255169)

http://europepmc.org/abstract/MED/26890358

28 February 2018

title

α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration. (English)

1 reference

http://europepmc.org/abstract/MED/26890358

28 February 2018

author

Miriam Royo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Antonio Villaverde

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jaume Veciana

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jordi Faraudo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Daniel Pulido

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Simo Schwartz

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Nora Ventosa

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Ingrid Cabrera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ibane Abasolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

José L Corchero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Elisa Elizondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Pilar Rivera Gil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Evelyn Moreno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Santi Sala

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dolores Bueno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Elisabet González-Mira

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Merche Rivas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Marta Melgarejo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Fernando Albericio

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Maria F García-Parajo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

18 February 2016

1 reference

http://europepmc.org/abstract/MED/26890358

28 February 2018

published in

Advanced Healthcare Materials

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

829-840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Enzyme replacement therapy for Fabry disease: a systematic review of available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Alpha-galactosidase A in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Gene therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Gene therapy progress and prospects: gene therapy of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Gene therapy for lysosomal storage diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Targeting glycosylation as a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Physico-chemical stability of colloidal lipid particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Physicochemical properties of protein-coated gold nanoparticles in biological fluids and cells before and after proteolytic digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Nanoparticles: Tracking protein corona over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Preparation of uniform rich cholesterol unilamellar nanovesicles using CO2-expanded solvents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Multifunctional nanovesicle-bioactive conjugates prepared by a one-step scalable method using CO2-expanded solvents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

New strategies for enzyme replacement therapy for lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Integrated approach to produce a recombinant, His-tagged human α-galactosidase A in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Understanding biophysicochemical interactions at the nano-bio interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

The molecular defect leading to Fabry disease: structure of human alpha-galactosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Positioning of proteins in membranes: a computational approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Targeting of drugs and nanoparticles to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Comparative evaluation of alpha-galactosidase A infusions for treatment of Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

An in vitro model of Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

VMD: visual molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

Enzymatic characterization of highly stable human alpha-galactosidase A displayed on magnetic particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500746

21 January 2018

Identifiers

DOI

10.1002/ADHM.201500746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890358%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference